Brooke Birling, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1420 Algoma St, New London, WI 54961 Phone: 920-982-8300 |
Leah M Lemke, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2450 |
Jay T Rust Jr., PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2463 |
Teasha L Kaepernick, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2291 Fax: 920-531-2207 |
Carolyn Zabor, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1405 Mill St, New London, WI 54961 Phone: 920-531-2400 Fax: 920-531-2450 |
News Archive
Scientists from the DZNE sites in G-ttingen and Bonn, the UMG as well as from the US participated in this basic research project on Alzheimer's disease. The study is published in "EMBO Molecular Medicine".
Every day, a school bus drops off as many as 45 children at a community eye clinic on Chicago's South Side. Many of them are referred to the clinic after failing vision screenings at their public schools.
A team of researchers at Robert Gordon University has secured a six figure sum from Sparks, a leading children's medical research charity, to develop a revolutionary treatment for a rare genetic disorder.
Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test.
On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.
› Verified 5 days ago